Design
Review
Answers are grounded in this paper and cite their sources.
This paper discusses the prothrombinase complex and Factor Xa as emerging therapeutic targets for small molecule inhibitors.
Click to increase image sizeClick to decrease image sizeKey Words: Factor XaProthrombinase complexAnticoagulant activityAntithrombotic activityTransition-state inhibitorsNon-peptide reversible inhibitors
No takes yet. Share an insight, caveat, or question.
Robert M. Scarborough (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: